Urinary Phthalate Levels Associated with the Risk of Nonalcoholic Fatty Liver Disease in Adults: The Korean National Environmental Health Survey (KoNEHS) 2012–2014

Urinary Phthalate Levels Associated with the Risk of Nonalcoholic Fatty Liver Disease in Adults: The Korean National Environmental Health Survey (KoNEHS) 2012–2014

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. Recent experimental studies suggested that phthalates might induce NAFLD. Therefore, this study aimed to investigate the relationship between phthalates metabolites and NAFLD in the human population. This cross-secti...

Full description

Bibliographic Details
Main Authors:	Yun-Jung Yang, Taehyen Kim, Yeon-Pyo Hong
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	International Journal of Environmental Research and Public Health
Subjects:	phthalates hepatic steatosis index nonalcoholic fatty liver disease Korean National Environmental Health Survey
Online Access:	https://www.mdpi.com/1660-4601/18/11/6035

Similar Items

Association between Blood Mercury Levels and Non-Alcoholic Fatty Liver Disease in Non-Obese Populations: The Korean National Environmental Health Survey (KoNEHS) 2012–2014
by: Yun-Jung Yang, et al.
Published: (2021-06-01)

Association of exposure to phthalates and environmental phenolics with markers of kidney function: Korean National Environmental Health Survey (KoNEHS) 2015–2017
by: Inae Lee, et al.
Published: (2020-10-01)

Associations of urinary concentrations of phthalate metabolites, bisphenol A, and parabens with obesity and diabetes mellitus in a Korean adult population: Korean National Environmental Health Survey (KoNEHS) 2015–2017
by: Inae Lee, et al.
Published: (2021-01-01)

Characterization of urinary cotinine in non-smoking residents in smoke-free homes in the Korean National Environmental Health Survey (KoNEHS)
by: Jeonghoon Kim, et al.
Published: (2016-07-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
by: Marcin Banaszczak, et al.
Published: (2020-02-01)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
by: Judith Wylie-Rosett, et al.
Published: (2013-10-01)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
by: Mao YQ, et al.
Published: (2016-03-01)

Prevalence and Clinical Characteristics of Nonalcoholic Liver Disease in Type 2 Diabetes Mellitus Patients: A Crosssectional Study
by: Lakshmi Ravansamudram Hariharan, et al.
Published: (2021-04-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patient with nonalcoholic fatty liver diseas
by: Stergios A. Polyzos, et al.
Published: (2016-09-01)

Characterization of urinary cotinine concentrations among non-smoking adults in smoking and smoke-free homes in the Korean national environmental health survey (KoNEHS) cycle 3 (2015–2017)
by: Jeonghoon Kim, et al.
Published: (2021-07-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
by: Gang Xu, et al.
Published: (2021-04-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
by: Yingfei Xi, et al.
Published: (2020-01-01)

Transient Elastography Role in the Diagnosis of Nonalcoholic Fatty Liver Disease
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
by: Soleimani D, et al.
Published: (2020-07-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats
by: Kasimu G. Ibrahim, et al.
Published: (2019-03-01)

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
by: Alice Emma Taliento, et al.
Published: (2019-08-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Maternal phthalate and phthalate alternative metabolites and urinary biomarkers of estrogens and testosterones across pregnancy
by: Diana C. Pacyga, et al.
Published: (2021-10-01)

Nonalcoholic fatty liver disease in normal weight subjects: current concepts and approaches (literature review)
by: Yu.M. Stepanov, et al.
Published: (2020-08-01)

Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats
by: R.N. Silva, et al.
Published: (2014-09-01)

Effects of L-Carnitine and N-Acetylcysteine on nonalcoholic hepatic steatosis in rats
by: Cemal Nas, et al.
Published: (2019-06-01)

Phthalate replacement by fast fusing non-phthalate plasticizer
by: Tommie, Ibert
Published: (2016)

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
by: Simona Marchisello, et al.
Published: (2019-04-01)

Determination of Phthalate Metabolites in Human Serum and Urine as Biomarkers for Phthalate Exposure Using Column-Switching LC-MS/MS
by: Jee Yeon Jeong, et al.
Published: (2011-03-01)

Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults
by: Jing Luo, et al.
Published: (2018-11-01)

The State of Pancreatobiliary System and Intestinal Microflora in Children with Nonalcoholic Fatty Liver Disease
by: N.Yu. Zavgorodnya, et al.
Published: (2016-11-01)

Phthalates in Electronics: The Risks and the Alternatives
by: Michael G. Pecht, et al.
Published: (2018-01-01)

Noninvasive diagnosis of nonalcoholic fatty liver disease
by: Robert P. Myers
Published: (2009-01-01)

Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes
by: Orsu Prabhakar, et al.
Published: (2021-01-01)

Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes
by: Mohammad Shafi Kuchay, et al.
Published: (2021-08-01)

Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease
by: I V Kurbatova, et al.
Published: (2017-02-01)